Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,583 | -2,722 | -32,474 | -29,264 | -25,465 |
| Depreciation Amortization | 56 | 28 | 118 | 92 | 63 |
| Accounts receivable | -771 | -485 | -23 | -147 | -267 |
| Other Working Capital | -1,039 | -329 | -610 | -809 | -1,184 |
| Other Operating Activity | 969 | 570 | 22,132 | 22,040 | 21,787 |
| Operating Cash Flow | $-6,369 | $-2,938 | $-10,856 | $-8,088 | $-5,066 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -6 | -5 | -4 | -2 |
| Purchase Of Investment | N/A | N/A | -346 | -346 | -346 |
| Sale Of Investment | N/A | N/A | 803 | 803 | 290 |
| Investing Cash Flow | $-6 | $-6 | $453 | $454 | $-57 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 365 | 365 | N/A | N/A | N/A |
| Common Stock Issued | 7,929 | N/A | 545 | 9,737 | N/A |
| Other Financing Activity | -273 | -136 | 9,193 | 0 | 545 |
| Financing Cash Flow | $8,021 | $229 | $9,737 | $9,737 | $545 |
| Beginning Cash Position | 5,584 | 5,584 | 6,250 | 6,250 | 6,250 |
| End Cash Position | 7,229 | 2,869 | 5,584 | 8,354 | 1,671 |
| Net Cash Flow | $1,645 | $-2,715 | $-666 | $2,104 | $-4,579 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,369 | -2,938 | -10,856 | -8,088 | -5,066 |
| Capital Expenditure | N/A | -6 | -5 | -4 | -2 |
| Free Cash Flow | -6,369 | -2,944 | -10,862 | -8,091 | -5,068 |